Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures... Show more
NNCSF's Aroon Indicator triggered a bullish signal on September 10, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 118 similar instances where the Aroon Indicator showed a similar pattern. In of the 118 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The 10-day moving average for NNCSF crossed bullishly above the 50-day moving average on August 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for NNCSF moved out of overbought territory on September 02, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 38 cases where NNCSF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NNCSF as a result. In of 50 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for NNCSF turned negative on September 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at .
NNCSF moved below its 50-day moving average on September 25, 2025 date and that indicates a change from an upward trend to a downward trend.
NNCSF broke above its upper Bollinger Band on September 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NNCSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.482) is normal, around the industry mean (10.726). P/E Ratio (56.641) is within average values for comparable stocks, (55.245). NNCSF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.690). NNCSF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (5.886) is also within normal values, averaging (13.843).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNCSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSUVX | 23.40 | N/A | N/A |
Fidelity SAI US LowVolatility Idx | |||
ICISX | 13.65 | -0.09 | -0.66% |
VY® Columbia Small Cap Value II I | |||
EILGX | 19.25 | -0.13 | -0.67% |
Eaton Vance Atlanta Capital Focused Gr I | |||
CVERX | 15.40 | -0.13 | -0.84% |
Columbia Select Mid Cap Value Instl 2 | |||
ERISX | 16.61 | -0.14 | -0.84% |
Parametric International Equity R |
A.I.dvisor tells us that NNCSF and NHNKY have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and NHNKY's prices will move in lockstep.
Ticker / NAME | Correlation To NNCSF | 1D Price Change % | ||
---|---|---|---|---|
NNCSF | 100% | -10.71% | ||
NHNKY - NNCSF | 8% Poorly correlated | +1.48% | ||
NVYTF - NNCSF | 7% Poorly correlated | N/A | ||
POCI - NNCSF | 1% Poorly correlated | +0.69% | ||
MCRPF - NNCSF | 1% Poorly correlated | N/A | ||
NHNKF - NNCSF | 0% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To NNCSF | 1D Price Change % |
---|---|---|
NNCSF | 100% | -10.71% |
Pharmaceuticals category (388 stocks) | -7% Poorly correlated | +0.11% |
Pharmaceuticals: Other category (103 stocks) | -7% Poorly correlated | +0.17% |